Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | Director | November 20, 2023 | November 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date November 20, 2023 · Filed November 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,593 |
Reported balance
After 2023-11-20 transaction · row 1
1 source rowRow 1 · 2023-11-20 · Grant · Acquired 335 · Balance 16,593 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 335 | $597.60 | $200,196.00 |
DisclosureSEC source: 0000059478-23-000310 · wk-form4_1700602131.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,593 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000261 · wf-form4_166915605731417.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,087 Read SEC document |
| March 01, 2022 Filed Mar 7, 2022 22:06 UTC | ELI LILLY & Co LLY · Entity 2794 | PurchaseCommon Stock | 202 | $246.78 | $49,849.56 |
DisclosureSEC source: 0000059478-22-000092 · wf-form4_164669076634205.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,436 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:46 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000222 · wf-form4_163718559717387.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,181 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000174 · wf-form4_160575285762668.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,279 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 18:10 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,534 | $114.07 | $174,983.38 |
DisclosureSEC source: 0000059478-19-000306 · wf-form4_157427343481509.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 22:47 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,511 | $115.81 | $174,988.91 |
DisclosureSEC source: 0000059478-18-000276 · wf-form4_154275402294040.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,014 Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 15:34 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,924 | $83.18 | $160,038.32 |
DisclosureSEC source: 0000059478-17-000232 · wf-form4_151136479947502.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,283 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 22:23 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,088 | $76.64 | $160,024.32 |
DisclosureSEC source: 0000059478-16-000472 · wf-form4_148063102189495.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:34 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000219 · wf-form4_144908845080020.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,976 Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:05 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,155 | $67.29 | $145,009.95 |
DisclosureSEC source: 0000059478-14-000214 · wf-form4_141755433581244.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Read SEC document |
| November 29, 2013 Filed Dec 3, 2013 20:32 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 947 | $51.03 | $48,325.41 |
DisclosureSEC source: 0000059478-13-000100 · wf-form4_138610271248147.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.